Study of Axitinib in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas
Clinical trial NCT02129647 · COMPLETED
Trial details
- NCT number
- NCT02129647
- Sponsor
- NYU Langone Health
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-01
- Primary completion
- 2019-02-05
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.